Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

Both have very promising futures.

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

Published July 26, 2026 · Category: Finance

Overview

Dividend Kings are companies that have increased their dividends for 50 or more years in a row. If you're thinking of investing in one, you might be considering AbbVie (NYSE: ABBV) or Johnson & Johnson (NYSE: JNJ) stock. There are good reasons to invest in either -- or both -- and good reasons to favor dividend-paying stocks.

Here's a quick look at the two companies.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.